Most patients tolerate this frequency well, experiencing gradual appetite suppression and improved metabolic function
GLP-1 medications offer more than just physical results
Drug and vehicle were delivered daily at 3pm, four hours before the onset of the dark cycle, for all experiments
Nourishment Over Restriction A common experience with GLP-1s is reduced appetite
Define Medicines Use Review (MUR) and discuss the clinical and economic evidence supporting its implementation Explore examples of MUR practices from different regions Become familiar with the FIP MUR toolkit to support the advocacy and establishment of the service Moderator: - Marja Airaksinen, Chair of the FIP Working Group on Patient Safety - Finland Panellists: - Filipa Alves da Costa, Assistant Professor University of Lisbon - Portugal - Nai-Hwa Mei, Clinical Pharmacist Specialist Department of Pharmacy, Shin Kong Wu Ho-Su Memorial Hospital - China Taiwan - Matthew Hung, Clinical Staff Pharmacist St
Written By: Nikita Jha, BPharm Reviewed By: Pharmacally Editorial Team Eli Lilly reported detailed results from three Phase 3 ACHIEVE studies evaluating Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with type 2 diabetes